Ligand Pharmaceuticals Statistics
Total Valuation
TADAWUL:6050 has a market cap or net worth of SAR 572.73 million. The enterprise value is 572.46 million.
Market Cap | 572.73M |
Enterprise Value | 572.46M |
Important Dates
The next estimated earnings date is Wednesday, August 20, 2025.
Earnings Date | Aug 20, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TADAWUL:6050 has 6.70 million shares outstanding.
Current Share Class | 6.70M |
Shares Outstanding | 6.70M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -0.00% |
Owned by Insiders (%) | 25.01% |
Owned by Institutions (%) | 0.02% |
Float | 5.02M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 105.13 |
PB Ratio | 8.95 |
P/TBV Ratio | 8.95 |
P/FCF Ratio | 858.95 |
P/OCF Ratio | 765.12 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -17.44 |
EV / Sales | 105.08 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 858.54 |
Financial Position
The company has a current ratio of 0.39, with a Debt / Equity ratio of 0.60.
Current Ratio | 0.39 |
Quick Ratio | 0.35 |
Debt / Equity | 0.60 |
Debt / EBITDA | n/a |
Debt / FCF | 57.79 |
Interest Coverage | -7.60 |
Financial Efficiency
Return on equity (ROE) is -40.91% and return on invested capital (ROIC) is -10.14%.
Return on Equity (ROE) | -40.91% |
Return on Assets (ROA) | -6.51% |
Return on Invested Capital (ROIC) | -10.14% |
Return on Capital Employed (ROCE) | -29.32% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.03 |
Inventory Turnover | 1.93 |
Taxes
In the past 12 months, TADAWUL:6050 has paid 1.69 million in taxes.
Income Tax | 1.69M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.09% in the last 52 weeks. The beta is 0.94, so TADAWUL:6050's price volatility has been similar to the market average.
Beta (5Y) | 0.94 |
52-Week Price Change | -35.09% |
50-Day Moving Average | 94.63 |
200-Day Moving Average | 117.48 |
Relative Strength Index (RSI) | 29.56 |
Average Volume (20 Days) | 46,503 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TADAWUL:6050 had revenue of SAR 5.45 million and -32.82 million in losses. Loss per share was -4.90.
Revenue | 5.45M |
Gross Profit | -499,874 |
Operating Income | -22.67M |
Pretax Income | -31.13M |
Net Income | -32.82M |
EBITDA | -14.15M |
EBIT | -22.67M |
Loss Per Share | -4.90 |
Balance Sheet
The company has 38.81 million in cash and 38.53 million in debt, giving a net cash position of 271,840 or 0.04 per share.
Cash & Cash Equivalents | 38.81M |
Total Debt | 38.53M |
Net Cash | 271,840 |
Net Cash Per Share | 0.04 |
Equity (Book Value) | 63.96M |
Book Value Per Share | 9.55 |
Working Capital | -67.52M |
Cash Flow
In the last 12 months, operating cash flow was 748,548 and capital expenditures -81,767, giving a free cash flow of 666,781.
Operating Cash Flow | 748,548 |
Capital Expenditures | -81,767 |
Free Cash Flow | 666,781 |
FCF Per Share | 0.10 |
Margins
Gross Margin | -9.18% |
Operating Margin | -416.08% |
Pretax Margin | -571.40% |
Profit Margin | n/a |
EBITDA Margin | -259.74% |
EBIT Margin | n/a |
FCF Margin | 12.24% |
Dividends & Yields
TADAWUL:6050 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -5.73% |
FCF Yield | 0.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on January 29, 2025. It was a reverse split with a ratio of 0.167465.
Last Split Date | Jan 29, 2025 |
Split Type | Reverse |
Split Ratio | 0.167465 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 4 |